Cambridge, Massachusetts Saturday, May 10, 2025, 18:00 Hrs [IST] ...

Bridgewater, New Jersey Saturday, May 10, 2025, 15:00 Hrs [IST] ...

Bethesda, Maryland Saturday, May 10, 2025, 14:00 Hrs [IST] ...

US FDA approves Verastem’s Avmapki Fakzynja combo therapy to treat patients with KRAS-mutated recurrent low-grade serous ovarian cancer: Boston Saturday, May 10, 2025, 13:00 Hrs ...

Industry leaders, innovators, and regulators converged to explore the future of quality, compliance, and digital transformation in life sciences at the 5th Annual Pharma GMP & Quality Management 2025 ...

The Pharma Quality Excellence Awards 2025 ceremony marked a significant milestone in recognizing outstanding contributions to ...

Our Bureau, New Delhi Saturday, May 10, 2025, 12:30 Hrs [IST] ...

Asthma can be managed by medical treatment, lifestyle adjustments & environmental interventions: Dr Jakka: Shardul Nautiyal, Mumbai Saturday, May 10, 2025, 09:00 Hrs [IST] Despite ...

OmRx Oncology begins phase 2 trial of oral PD-L1 inhibitor OX-4224 in patients with non-small cell lung cancer: San Diego Saturday, May 10, 2025, 12:00 Hrs [IST] OmRx Oncology, or ...

Johnson & Johnson expands efforts to champion the nursing workforce globally: New Brunswick, New Jersey Saturday, May 10, 2025, 11:00 Hrs [IST] Johnson & Johnson announced the exp ...

In a significant policy shift aimed at optimizing raw material usage in pharma exports, the Directorate General of Foreign Trade (DGFT) has issued Public Notice amending the Standard Input Output ...

Beacon Therapeutics announces phase 2 interim 6 months data from DAWN trial of Laru-zova: London Friday, May 9, 2025, 18:00 Hrs [IST] Beacon Therapeutics Holdings Limited, a leadi ...